Biggest News Aggregation in the World
📰 Phase News

Page 1491 - Phase News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Phase. Real-time updates on events, politics, business and more.

Gamaleya Center completing phase 2 study of Sputnik V Light vaccine

Gamaleya Center completing phase 2 study of Sputnik V Light vaccine 13 February 2021 13:37 Share in: MOSCOW. KAZINFORM - Russia’s Gamaleya National Research Center for Epidemiology and Microbiology is finalizing phase 2 clinical trials of the Sputnik V Light coronavirus vaccine, Alexander Gintsburg, the center’s director, said in a televised interview with Rossiya-24 news channel on Friday, TASS reports. Related news «The Gamaleya cente...
Alexander Gintsburg Russia Gamaleya National Research Center Gamaleya Center Sputnikv Light Gamaleya National Research Center Gamaleya National Research Center For Epidemiology And Microbiology
Source: inform.kz

KGO ABC World News Tonight With David Muir February 13, 2021 01:36:00

It once and urged his supporters to fight more than a dozen types in that one speech. still the defense argued today, this is not incitement. >> no thinking person could seriously believe that the presidents january 6th speech on the ellipse was in any way an incitement to violence or insurrection. >> reporter: trumps team used just 2 1/2 hours of their 16 hours allotted to defend the president. >> let us be clear, this trial is about far more than president trump. it is about silencing and bann...
Donald Trump January 6th Speech January 6th 2 1 75 Million

COVID-19: New cases rise for second straight day, rate down from week ago

Northeast Tennessee reported a net increase of 219 novel coronavirus (COVID-19) infections on Thursday, its most in nearly two weeks, causing its seven-day new case rate to increase for the second-consecutive day. As of Thursday, the region was averaging 135.5 new cases per day over the last week, up from a low of 116.1 on Tuesday but still below last week’s high of 160. Sullivan County reported the most new cases with 89, while Carter County (+51) was the only other to report more than 50...
District Of Columbia United States Sullivan County Carter County Ballad Health Northeast Tennessee

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Ready Set Gold Corporation: Ready Set Gold Provides Update on Phase 1 Drilling Northshore Gold Project

Ready Set Gold Corporation: Ready Set Gold Provides Update on Phase 1 Drilling Northshore Gold Project Ready Set Gold Corp. (CSE: RDY) (FSE: 0MZ) ("Ready Set Gold" or the "Company") is pleased to provide an update on its ongoing drilling program at the Northshore Gold Project located in the Hemlo-Schreiber Greenstone Belt near the town of Schreiber, Ontario. The 3,000 m, Phase 1 diamond drilling program, as previously announced on January 26, 2021, is approaching 50% completed, and is progres...
Thunder Bay Christian Scovenna Peterm Dimmell Sean Kingsley National Instrument Ready Set Gold Corp

First photos of Tauranga 's $400m Winstone Wallboards plasterboard plant

First photos of Tauranga s $400m Winstone Wallboards plasterboard plant 12 Feb, 2021 06:00 PM 6 minutes to read An artist impression of what the major manufacturing and distribution facility will look like. Photo / Supplied An artist impression of what the major manufacturing and distribution facility will look like. Photo / Supplied The first construction phase of Taurangas $400 million plasterboard facility has begun in the Tauriko Business Estate - this initial phase costing almost $40m. ...
Bay Of Plenty New Zealand George Novak Nigel Tutt Barbara Dempsey Matt Cowley

Urovant Sciences Announces Progression of URO-902 Phase 2a Trial Following Positive Recommendation from the Data and Safety Monitoring Board

(1) Urovant Sciences (Nasdaq: UROV) announced today that the independent Data and Safety Monitoring Board (DSMB) has recommended the continuation of the phase 2a study of URO-902, a novel gene therapy product, in patients with overactive bladder (OAB) and urge urinary incontinence (UUI). URO-902 has the potential to be the first gene therapy for patients with OAB. Following the recommendation of the DSMB, Urovant is proceeding with opening cohort 2 of the study with a dose of 48 mg or placebo. ...
New York United States City Of United Kingdom Sumitomo Dainippon Pharma Ryan Kubota

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science